The articles and resources below allow for discussion. Take advantage of our comments section, and feel free to share the content with colleagues.
Labor Day 2020: A Salute to Health Care Workers and Medtech Innovators on the Frontlines during the COVID-19 Pandemic
By Christopher White, Chief Operating Officer, General Counsel and Secretary at AdvaMed Note: This article was originally published on LinkedIn on September 2. View the original post here. For many in the United States, Labor Day signifies the unofficial end to
Getting Back to Normal: Coronavirus Response Spotlights MedTech’s Critical Contributions To Public Health
By Christopher White, Chief Operating Officer, General Counsel and Secretary at AdvaMed Note: This article was originally published on LinkedIn on August 14. View the original post here. Back in the pre-pandemic “old days” I regularly posted blogs here on LinkedIn
Coronavirus: Extend therapies to ease cancer backlog, doctors tell Hancock
by Katie Gibbons, Reporter, The Times Note: This article was originally published on The Times Cancer patients are travelling miles for radiotherapy as advanced equipment sits unused in half of NHS trusts because of bureaucratic delays, health professionals say. They
Doing Good… While Doing Good
By Nancy Travis, Vice President, Global Compliance and Governance at AdvaMed Note: This article was originally published on LinkedIn As many of you know, I work for AdvaMed, a trade association that represents medical technology companies – companies that have been
Contacts for Medical Devices During the COVID-19 Pandemic
The FDA provided guidance for who to contact at FDA regarding COVID-19 issues for medical devices. View the full document here. Industry Hotline: Coronavirus COVID-19 Diagnostic Tests and Shortages For Industry Questions: COVID-19 Diagnostic Tests, and COVID-19 device shortages, including
NIH mobilizes national innovation initiative for COVID-19 diagnostics
The National Institutes of Health today announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic. With a $1.5 billion investment from